About Japan Community Health care Organization Kurume General Hospital
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Japan Community Health care Organization Kurume General Hospital
During the past decade, Japan Community Health care Organization Kurume General Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
2022-04-20
2024-06-30
Active, not recruiting
688
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Japan Community Health care Organization Kurume General Hospital
According to Clinical.Site data, the most researched conditions in "Japan Community Health care Organization Kurume General Hospital" are
"Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Japan Community Health care Organization Kurume General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Japan Community Health care Organization Kurume General Hospital
Most popular intervention types in "Japan Community Health care Organization Kurume General Hospital" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Endocrine therapy" (1 trials), "Herceptin®" (1 trials), "PF-05280014" (1 trials), "Paclitaxel" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Japan Community Health care Organization Kurume General Hospital
The vast majority of trials in "Japan Community Health care Organization Kurume General Hospital" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Japan Community Health care Organization Kurume General Hospital
Currently, there are NaN active trials in "Japan Community Health care Organization Kurume General Hospital".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Japan Community Health care Organization Kurume General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Japan Community Health care Organization Kurume General Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".